Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$11,390,736
+$1,532,785 QoQ
Shares Held
45,266
-0.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.65%
of 13F equity value
Holder Rank
#862
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Iowa State Bank holds $35,695,888 across 7 Drug Manufacturers - General names. ABBV ranks #1 (31.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
45,266 | $11,390,736 | |
| 2 | JNJ |
Johnson & Johnson
|
33,394 | $8,481,074 | |
| 3 | LLY |
ELI LILLY & Co
|
5,120 | $6,141,082 | |
| 4 | AMGN |
Amgen Inc
|
9,653 | $3,495,544 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
18,782 | $2,372,917 | |
| 6 | PFE |
Pfizer Inc
|
87,501 | $2,107,024 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
29,634 | $1,707,511 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,390,736 | 45,266 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $9,857,951 | 45,326 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $11,508,127 | 50,366 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $11,731,437 | 50,667 | Shares | Sole | 2025-10-03 | |
| 2025-06-30 | $9,620,684 | 51,830 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $10,873,668 | 51,898 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $9,491,845 | 53,415 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $10,485,595 | 53,097 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $8,796,917 | 51,288 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $9,245,217 | 50,770 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $8,051,776 | 51,957 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $8,737,151 | 58,615 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $7,785,641 | 57,787 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $9,437,253 | 59,216 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $10,307,808 | 63,782 | Shares | Sole | 2023-01-06 | |
| 2022-09-30 | $8,279,816 | 61,693 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $9,784,932 | 63,887 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $10,570,868 | 65,208 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $9,212,073 | 68,036 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $6,973,471 | 64,647 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $7,798,179 | 69,231 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $7,513,822 | 69,431 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $7,629,830 | 71,207 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $6,148,291 | 70,194 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $6,326,326 | 64,436 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $4,989,606 | 65,489 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||